secwatch.observer — SEC 8-K summary
======================================

Issuer:     Progyny, Inc. (PGNY)
CIK:        0001551306
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001551306-25-000006
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Progyny expects Q4 2024 revenue, net income, Adjusted EBITDA slightly above prior guidance
--------------------------------------------------------------------------------

- Company updates guidance at JPM Healthcare Conference; Q4 results expected slightly above November ranges.
- Previous guidance assumed member activity flat to down vs Q3 2024; improved pacing drove the beat.
- CEO Pete Anevski to present on Jan 14, 2025 at 7:30 a.m. PT; audiocast available on investor site.
- No specific dollar amounts or revised ranges provided in the press release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551306/000155130625000006/0001551306-25-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551306/000155130625000006/pgny-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001551306-25-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer